Compare FRD & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRD | SMTI |
|---|---|---|
| Founded | 1965 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.2M | 313.5M |
| IPO Year | 1995 | 2008 |
| Metric | FRD | SMTI |
|---|---|---|
| Price | $39.26 | $35.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 47.1K | ★ 191.0K |
| Earning Date | 06-11-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | ★ $121,157,278.00 | $15,586,976.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | N/A | $12.48 |
| P/E Ratio | $22.02 | ★ N/A |
| Revenue Growth | ★ 55.82 | 32.47 |
| 52 Week Low | $16.55 | $16.05 |
| 52 Week High | $48.77 | $35.34 |
| Indicator | FRD | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 67.59 |
| Support Level | $30.68 | $33.99 |
| Resistance Level | $39.07 | $35.34 |
| Average True Range (ATR) | 1.66 | 0.21 |
| MACD | -0.50 | -0.17 |
| Stochastic Oscillator | 7.25 | 55.56 |
Friedman Industries Inc is a manufacturer and processor of metals and operates in two reportable segments: flat-roll products and tubular products. The flat-roll product segment consists of flat-roll processing facilities located in Hickman, Arkansas; Decatur, Alabama; Miami, Florida; East Chicago, Indiana; Granite City, Illinois and Sinton, Texas and a flat-roll distribution facility located in Orlando, Florida. The tubular product segment consists of the Company's Texas Tubular Products division (TTP) located in Lone Star, Texas. TTP operates two electric resistance welded pipe mills with a combined outside diameter (OD). Its products are flat-roll products and tubular products.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.